Palliative RT

RADIATION4 trials

Sponsors

University Health Network, Toronto, Korea Cancer Center Hospital, European Organisation for Research and Treatment of Cancer - EORTC, University of Wisconsin, Madison

Conditions

Bladder CancerColon CancerEsophageal CancerGastric CancerGynecologic CancerHead and Neck CancerHead and Neck Squamous Cell CarcinomaHepatic Metastasis

Early Phase 1

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

RecruitingNCT06308913

University of Wisconsin, MadisonHead and Neck Squamous Cell Carcinoma

Start: 2024-09-18End: 2027-08-31Target: 12Updated: 2025-07-15

Phase 2

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

CompletedNCT00923897

University Health Network, TorontoHepatic Metastasis, Hepatocellular Carcinoma

Start: 2007-02-28End: 2018-09-26Updated: 2019-06-18

SBRT for Extra-cranial Oligorecurrent Tumor

Korea Cancer Center HospitalRecurrent Cancer

Start: 2016-03-31End: 2020-03-31Target: 1Updated: 2016-03-03

Unknown Phase

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

RecruitingNCT04498767

European Organisation for Research and Treatment of Cancer - EORTCBladder Cancer, Colon Cancer, Esophageal Cancer +12

Start: 2021-06-10End: 2030-02-01Target: 200Updated: 2024-08-26

Related Papers

Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results

Signal Transduction and Targeted Therapy2025-03-175 citations